- EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCsIn this segment, Dr. Sands asks the panel to discuss the emerging role of TROP2-directed antibody–drug conjugates in EGFR-mutated non-small cell lung cancer. Dr. Wakelee and Dr. Cooper explain that…onclive · 2mo ago↗ source
- Future Directions in Relapsed and Refractory Multiple Myelomaonclive · 2mo ago↗ source
- Dr Parikh on the Feasibility and Importance of Immunotherapy Trials in Anal CancerAparna R. Parikh, MD, discusses how trials like PODIUM-303 are reshaping the treatment paradigm for squamous cell anal carcinomas.onclive · 2mo ago↗ source